West Pharmaceutical Services, Inc. (WST) closed at $404 on November 19, 2026, a decline of 2.51% over the prior 24 hours. The move extended a modest weekly pullback, with shares also down 2.21% over the past seven days.
Despite the recent softness, WST retains a 30-day gain of 5.20%, suggesting the stock has held up reasonably well over the broader monthly window. The company's market capitalization stands at $28.85 billion.
West Pharmaceutical Services is a manufacturer of containment and delivery systems for injectable medicines and healthcare products. The stock's near-term pressure comes against the backdrop of a still-positive monthly performance trend.
The gap between the 30-day gain and the shorter-term losses indicates that some of WST's October and early November advance has begun to unwind, though the monthly return remains in positive territory as of Wednesday's close.



